Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8238216.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twelve patients with intraocular Lyme borreliosis suffering from vitreitis were treated with ceftriaxone intravenously. Eight patients had definitive Lyme borreliosis, and tentative diagnosis was made in four patients. After treatment with ceftriaxone, all 12 patients were followed up for more than one year. Vitreitis diminished in all patients and visual acuity improved in six patients. The best results were achieved in patients with definitive Lyme borreliosis.
Medical subject headings
- Ceftriaxone
- Eye Infections, Bacterial
- Lyme Disease
- Vitreous Body